Rewind Therapeutics

Foundation date

27/09/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

We discover and develop innovative first-in-class remyelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases.

Upcoming events

Latest news

  • Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

    13 hours ago

  • Indigo Diabetes announces first participant enrolled in the SHINE clinical trial

    Thursday September 29th 2022

  • FINTEPLA®▼ (fenfluramine) approved in Japan for the treatment of seizures associated with Dravet syndrome

    Tuesday September 27th 2022